title: Is cardiac troponin T serum level an accurate surrogate for acute doxorubicin-related myocardial injury?
authors.forename: G
authors.initials: G
authors.lastname: Ferretti
authors.forename: M
authors.initials: M
authors.lastname: Mandalà
authors.forename: E
authors.initials: E
authors.lastname: Bria
authors.forename: P
authors.initials: P
authors.lastname: Papaldo
authors.forename: P
authors.initials: P
authors.lastname: Carlini
authors.forename: A
authors.initials: A
authors.lastname: Fabi
authors.forename: M
authors.initials: M
authors.lastname: Milella
authors.forename: E M
authors.initials: EM
authors.lastname: Ruggeri
authors.forename: C
authors.initials: C
authors.lastname: Nisticò
authors.forename: F
authors.initials: F
authors.lastname: Cognetti
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood*; D004317:Doxorubicin / Q000009:adverse effects*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood* / Q000139:chemically induced* / Q000175:diagnosis; D011379:Prognosis; D020107:Troponin T / Q000097:blood*
chemical_list: D000903:Antibiotics, Antineoplastic; D015415:Biomarkers; D020107:Troponin T; D004317:Doxorubicin